Literature DB >> 16621674

Evaluation of povidone-iodine as a disinfectant solution for contact lenses: antimicrobial activity and cytotoxicity for corneal epithelial cells.

Ryoji Yanai1, Naoyuki Yamada, Kiichi Ueda, Motoharu Tajiri, Toru Matsumoto, Keiji Kido, Shigeru Nakamura, Fumio Saito, Teruo Nishida.   

Abstract

Povidone-iodine (PVP-I) possesses broad-spectrum antimicrobial activity and is used clinically as a disinfectant. We evaluated the disinfectant properties and safety of PVP-I for use as a contact lens solution. The concentrations of PVP-I required to reduce the number of Staphylococcus aureus or Candida albicans by 3 log units were lower than were those of hydrogen peroxide, polyhexamethylene biguanide (PHMB), and benzalkonium chloride (BAK). The cytotoxicity of PVP-I for cultured human corneal epithelial (HCE) cells was less than that of the other three agents. The safety margin for PVP-I was thus greatest among the tested compounds. PVP-I appears suited for use as a contact lens disinfectant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621674     DOI: 10.1016/j.clae.2006.02.006

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  13 in total

1.  Autophagy inhibitors as a potential antiamoebic treatment for Acanthamoeba keratitis.

Authors:  Eun-Kyung Moon; So-Hee Kim; Yeonchul Hong; Dong-Il Chung; Youn-Kyoung Goo; Hyun-Hee Kong
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

2.  Capsular bag irrigation using 0.025% povidone-iodine in balanced salt solution PLUS for the treatment of postoperative endophthalmitis.

Authors:  Kyuen Otani; Hiroyuki Shimada; Hiroyuki Nakashizuka; Hirofumi Okubo
Journal:  Int Ophthalmol       Date:  2017-07-08       Impact factor: 2.031

Review 3.  Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition.

Authors:  Mallesh Kurakula; G S N Koteswara Rao
Journal:  J Drug Deliv Sci Technol       Date:  2020-09-02       Impact factor: 3.981

4.  Efficacy of Korean Multipurpose Contact Lens Disinfecting Solutions against Acanthamoeba castellanii.

Authors:  Eun-Kyung Moon; Hye-Ryun Park; Fu-Shi Quan; Hyun-Hee Kong
Journal:  Korean J Parasitol       Date:  2016-12-31       Impact factor: 1.341

5.  Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study.

Authors:  Kensaku Miyake; Norihiko Yokoi
Journal:  Clin Ophthalmol       Date:  2017-03-17

6.  Evaluation of Retinal Function and Pathology After Intravitreal Injection of Povidone-Iodine and Polyvinyl Alcohol-Iodine in Rabbits.

Authors:  Hiroyuki Shimada; Kimiko Kato; Kazuumi Ishida; Takanori Yamaguchi; Kei Shinoda
Journal:  Transl Vis Sci Technol       Date:  2020-04-15       Impact factor: 3.283

7.  Regarding comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population.

Authors:  Kevin Michael Wells; Kapil G Kapoor; S K Gibran
Journal:  Indian J Ophthalmol       Date:  2013-04       Impact factor: 1.848

8.  The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea: The results of a consort-compliant randomized controlled trial.

Authors:  Yuan He; Jia Li; Jingfen Zhu; Ying Jie; Ningli Wang; Jun Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  In Situ Electrospinning Iodine-Based Fibrous Meshes for Antibacterial Wound Dressing.

Authors:  Guo-Sai Liu; Xu Yan; Fang-Fang Yan; Fu-Xing Chen; Long-Yun Hao; Shao-Juan Chen; Tao Lou; Xin Ning; Yun-Ze Long
Journal:  Nanoscale Res Lett       Date:  2018-10-03       Impact factor: 4.703

Review 10.  Cataract surgery and dry eye disease: A review.

Authors:  Khayam Naderi; Jack Gormley; David O'Brart
Journal:  Eur J Ophthalmol       Date:  2020-06-09       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.